 |
Italian Scientists and Scholars of North America Foundation
|
|
Home > USA > Meet Italy at Bio 2007
ARETA INTERNATIONAL
Via Roberto Lepetit, 34- 21040 Gerenzano (VA), ITALY
Telephone: 0039 02 96489264
Fax: 0039 02 96489260
Web site: www.aretaint.com
E-mail: areta@aretaint.com
Contact: Ms. Maria Luisa Nolli (CEO)
At a Glance
Status: SME
Date of foundation: 1999
Employees: 14
Turnover: 1.000.000,00 Euro
% export: 20%
Export destinations: Europe, USA, Japan
Main Activity
Areta International develops new, rapid and reliable methods and technologies to produce molecules and cells for diagnosis as well as for therapy.
Its mission is the contract process development and manufacturing of tailored-made lots of potential biodrugs (monoclonal antibodies, cells for cell therapy, recombinant proteins and diagnostic kits) for cancer, central nervous system and rare metabolic disease therapy as well as for diagnosis.
Company Strengths
LICENSES/TRADE MARKS/QUALITY CERTIFICATIONS/PATENTS: Adult and Stem Cells for Cell Therapy, Antibodies for Immunotherapy, Recombinant Proteins for Enzymatic Therapy.
LICENSES/TRADE MARKS/QUALITY CERTIFICATIONS/PATENTS: ISO 9001:2000, GMP.
INNOVATIVE PROCESSES/SERVICES/PRODUCTS: Production with single use disposable bioreactors, tailored-made batches for clinical trials.
NETWORKING: ARETA is in contact with several universities, research centers and companies.
R&D CAPACITY: development of process for cells and their products.
EXPERTISE: mammalian cells, antibodies biochemistry, protein purification.
Customer References
- Pharmaceutical Industries
- Biotech Companies
- Research Institutes
- Universities
Sector
BIOTECHNOLOGY
MEDICAL BIOTECHNOLOGY
-biopharmaceutical
-bioprocess
-drug development
-contract
-immunology
-process development
-research & development
Type of Cooperation
GENERAL CO-OPERATION
-DEVELOPMENT OF NEW PRODUCTS
-IDENTIFICATION OF NEW CUSTOMERS
-JOINT CREATION OF AN ENTERPRISE, CONSORTIUM OR HOLDING
-NEW PROJECTS DEVELOPMENT
|
|
